[Comparison of Merck and Pasteur plasma-derived hepatitis B vaccines in 2 populations of hemodialysis patients].
In reporting the preliminary data on the anti-B hepatitis vaccination study, the paper compares the two plasma-derived vaccines on the market, Pasteur Hevac-B and HB-Vax M.S.D. in two groups of hemodialyzed subjects. It briefly described the properties of the two vaccines and examines the respective vaccination protocols, doses and administration methods. After reporting the data on the two groups considered and the results in each one, the paper concludes that the M.S.D. vaccine is the most efficacious for hemodialyzed subjects.
Volterrani
A
A
U.S.L. RM/35 - Ospedale di Anzio, Centro per la Vaccinazione Anti-Epatite B.
Di Giandomenico
G
G
Di Giandomenico
F W
FW
D006514:Hepatitis B Surface Antigens / Q000032:analysis; D017325:Hepatitis B Vaccines; D006801:Humans; D007117:Immunization, Secondary; D008875:Middle Aged; D006435:Renal Dialysis; D013997:Time Factors; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage
D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines
Confronto tra la vaccinazione anti-epatite B con vaccini plasmaderivati Merck e Pasteur in due popolazioni di emodializzati.